Kamada (KMDA) Research & Development (2012 - 2026)

Kamada (KMDA) reported Research & Development of $2.2 million for Q1 2026, down 48.63% on a YoY basis from $4.2 million in Q1 2025, and down 24.64% quarter-over-quarter from $2.9 million in Q4 2025.

Kamada (KMDA) Research & Development (2012 - 2026) Analysis & Trends

Kamada has reported Research & Development for 15 years, with the latest figure at $2.2 million in Q1 2026.

  • For the quarter ending Q1 2026, Research & Development fell 48.63% year-over-year to $2.2 million; the trailing twelve-month figure through Mar 2026 stood at $7.7 million (down 25.38% YoY), and the FY2025 full-year result was $13.0 million, down 14.42% from the prior year.
  • Research & Development for Q1 2026 stood at $2.2 million, down from $2.9 million in the prior quarter.
  • The five-year high for Research & Development was $4.4 million in Q1 2022, with the low at $3118.0 in Q3 2022.
  • Historically, Research & Development has averaged $2.5 million across 5 years, with a median of $2.9 million in 2025.
  • Annual changes were most pronounced in 2023 — Research & Development plunged 99.93% — and 2024, when it surged 132830.98%.
  • Kamada's Research & Development stood at $3.0 million in 2022, then climbed by 8.29% to $3.2 million in 2023, then fell by 17.47% to $2.7 million in 2024, then grew by 8.27% to $2.9 million in 2025, then retreated by 24.64% to $2.2 million in 2026.
  • The last three Research & Development figures came in at $2.2 million (Q1 2026), $2.9 million (Q4 2025), and $2.6 million (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) R&D (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 222.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 180.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 138.20 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 934,363.43
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 296.20 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 97.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn 103.35 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 39.38 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn 46.94 Mn
10 Kamada 505.05 -73.15 Mn 19.12 Mn 2.18 Mn

Historic Data

Download Data
DateValue
Mar 31, 2026 2.18 Mn
Dec 31, 2025 2.89 Mn
Sep 30, 2025 2.64 Mn
Jun 30, 2025 3,219.00
Mar 31, 2025 4.25 Mn
Dec 31, 2024 2.67 Mn
Sep 30, 2024 3.41 Mn
Jun 30, 2024 4,803.00
Mar 31, 2024 4.30 Mn
Dec 31, 2023 3.24 Mn
Sep 30, 2023 3.18 Mn
Jun 30, 2023 4.28 Mn
Mar 31, 2023 3,231.00
Dec 31, 2022 2.99 Mn
Sep 30, 2022 3,118.00
Jun 30, 2022 2.64 Mn
Mar 31, 2022 4.42 Mn
Dec 31, 2021 3.45 Mn
Sep 30, 2021 2.55 Mn
Jun 30, 2021 2.74 Mn